Cell Culture Market To Expand At A Robust CAGR Of 9.5% From 2017 To 2025

The global cell culture market was valued at around US$ 13,000.0 Mn in 2016 and is anticipated to register a stable CAGR of over 9.5% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The global cell culture market is likely to be driven by development of new products, technological advancements, and increasing use of single-use bioprocessing systems during the forecast period. The cell culture market in Asia Pacific is expanding at a CAGR of above 10.0%, due to high unmet clinical needs, development of the health care sector, and increased focus on R&D activities in the region.

Read Report Overview: https://www.transparencymarketresearch.com/cell-culture-market.html

Increasing Demand and Approvals for Biosimilar Products and Other Biologic Therapeutics to drive the Market

Cell culture is one of the most important steps in the production of biosimilar antibodies, as cell culture helps increase the efficiency and productivity and reduces the cost of manufacture. Increasing demand and approvals for biosimilar products and other biologic therapeutics for the treatment of chronic diseases in developed as well as developing countries has augmented the demand for efficient and cost-effective products. This rising demand is, in turn, anticipated to drive the global cell culture market during the forecast period. Moreover, increasing demand for cost-effective and highly efficient cell culture products such as bioreactors, mediums, reagents, and sera for the production of high-yield cell lines has led to increase in the number of new product launches. This factor is anticipated to provide lucrative opportunities to the global cell culture market during the forecast period. Major manufactures are constantly trying to expand their product portfolio by launching new and advanced systems for large-scale production which is cost-effective and which involves low risk of contamination. For instance, in 2018, Merck launched capsule filters that are designed to decrease the risk of contamination in a bioreactor. These filters are used for separation of mycoplasma and bacteria from cell culture mediums. However, ethical issues associated with the use of fetal bovine serum, stringent regulations, and high cost of infrastructure required for cell culture are expected to hamper the global cell culture market during the forecast period.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Technological Advancements in Cell Culture Production Mediums and Instruments are likely to fuel the Demand for Protein-based Therapeutics

Based on product, the global cell culture market has been categorized into instruments, mediums, sera, and reagents. The instruments segment has been sub-categorized into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. Technological advancements for improving the efficiency and reducing the risk of cross contamination are expected to drive the instruments segment during the forecast period. The mediums segment has been sub-segmented into chemically defined mediums, classical mediums, protein-free mediums, lysogeny broths, serum-free mediums, and specialty mediums. High efficiency of different mediums used for cell culture production is anticipated to drive the mediums segment during the forecast period. The sera segment has been sub-divided into fetal bovine serum and others. Sera are used as cell culture supplements consisting of growth factors, nutrients, and other important trace elements. The reagents segment has been sub-categorized into albumin, amino acids, attachment factors, growth factors & cytokines, protease inhibitors, thrombin, and others. Applications such as stem cell research offer high potential for growth of the cell culture market in the near future. Stem cell culture assists in the standardization of drug production and enables production of a wide variety of cell lines and related products. Traditional pharmaceutical therapeutics help in treating only disease symptoms, whereas stem cell therapies assist in treating the cause of the disease. Thus, further research in the field of stem cell culture for the development of drugs offers high potential for the market in the near future.

Request Report For Discount: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=405

Increasing Research and Development Expenditure to fuel Pharmaceutical Companies Segment

In terms of end-user, the global cell culture market has been divided into biotechnology companies, pharmaceutical companies, academic institutes, and research institutes. The pharmaceutical companies segment dominated the cell culture market in 2016. The trend is anticipated to continue during the forecast period as well. The segment is expected to hold more than 29.0% of the market share by 2025. Growth of the segment is attributable to increasing number of biotechnology companies and rising strategic collaborations among market players to expand the presence worldwide. The pharmaceutical companies segment is likely to be followed by the biotechnology companies segment during the forecast period.

Increasing Focus of Key Players in Asia Pacific on Creation of more Opportunities for Cell Culture Market

Geographically, the global cell culture market has been divided into major five geographical regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold a major share of the market during the forecast period, owing to presence of key players in the region, increasing research and development activities, and new drug approvals. Shift in trend toward continuous processing is also anticipated to drive the cell culture market in North America from 2017 to 2025. The Asia Pacific cell culture market was valued at around US$ 2,900.0 Mn in 2016 and is anticipated to witness significant growth from 2017 to 2025. Increasing focus of key players on expansion in the Asia Pacific region, large untapped population, and rising awareness about health care promote the growth of the cell culture market in Asia Pacific. For instance, in 2016, Thermo Fisher expanded its Fisher BioServices and cryogenic service facilities in Japan.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=405

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

This release was published on openPR.